AgileAI Labs Unveils Spec2TestAI's Natural Language No-Code Automated Testing Tool
Software Development Teams build an end-to-end project knowledge base that self-improves generating enhanced, fully traceable project assets from Specs to Tests
Spec2TestAI™ fundamentally redefines how agile teams approach quality assurance. It automatically enhances requirements, generates comprehensive test cases through transparent mathematical modeling, and predicts potential code failures. This proactive methodology drastically reduces costly rework and significantly accelerates time-to-market.
The Spec2TestAI™ end-to-end software development platform is engineered to close critical interpretation gaps between business objectives, development, and testing, leveraging advanced AI to enhance requirements and predict and prevent potential code failures. "Predictive capability and automated framework output not only drastically cut down on costly rework but also ensure robust standards and security compliance, ultimately delivering higher-quality software and fostering team collaboration," said
Key Benefits
The platform offers several critical advantages that streamline the entire SDLC for agile teams:
- Better Refined Requirements: AI clarifies specs, closes gaps, reduces rework through predictive software defect prevention.
- One-Click Test Case Generation: Prioritized, traceable, run-ready automated test case generation.
- Integrated Security: AI generates security requirements and tests alongside functional ones. Upload your own policies for full coverage, analysis, and assurance.
- Real-Time Project Assistance: Step-Specific AI Assistant provides deeply informed project-specific responses and reports in seconds.
- Predictive DevTestOps (Patent pending): Forecast failures before code executes -- Identify gaps, code fail points, and vulnerabilities.
- Automated Framework Output: Generates BDD cucumber files and multi-language scripts (Java, JavaScript, Python, etc.)
- Spec2Code AI Prompts (Patent pending): Creates tool-ready traceable coding prompts directly from requirements
- Project Knowledge Base: build an end-to-end cumulative project knowledge base that self-improves as your team continues to generate enhanced project assets
Empowering No-Code Test Automation
Spec2TestAI™'s newest capability introduces no-code natural language automated test execution. This innovation allows users to build and run software tests using plain English, eliminating the need for complex programming languages. This approach democratizes quality assurance, enabling non-technical stakeholders like business analysts, product managers, and manual testers to directly participate in creating and executing test scripts. The platform also supports uploading additional tests and has partnered with GenRocket's Data Connect™ to seamlessly integrate synthetic data generation, facilitating testing of sensitive applications at scale with the click of a button.
Availability
Spec2TestAI™ is available immediately through AgileAI Labs, Inc. and technology partners worldwide.
About AgileAI Labs, Inc
AgileAI Labs, Inc. is committed to SDLC quality improvement by delivering solutions that streamline the software development process, enhance product quality, and close interpretation gaps between development and testing. Partners and customers alike are reaping the benefits of quality driven AI throughout the SDLC.
Further information is available at https://agileailabs.com.
Contact: AgileAI Labs, Inc.
Missy Trumpler
561-315-8031
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/agileai-labs-unveils-spec2testais-natural-language-no-code-automated-testing-tool-302809939.html
SOURCE AgileAI Labs, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AFRRI/NIAID Designs Proprietary PBI-BM2.5 Protocol to Evaluate Valion Bio's (NASDAQ: VBIO) Entolimod as the First and Only Treatment for GI-ARS
- Aftermath Silver Intercepts 30.0 metres of 77 g/t Silver + 2.93% High Grade Copper at Berenguela
- Cardiol Therapeutics Reports Results of 2026 Annual General Meeting of Shareholders
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share